Sign in to your account
or
By signing in you agree to our
Terms & conditions
 and 
Privacy policy
Sku Image
Sku Image
sold out tag

Emtux Solution for Infusion

Rituximab (500mg)
Genuine
Authenticity Assured
Prescription
required
NPPA Regulated
Show Details
Emtux Solution for Infusion is used in the treatment of non-Hodgkin lymphoma (NHL), rheumatoid arthritis, blood cancer (chronic lymphocytic leukemia), granulomatosis with polyangiitis and microscopic polyangiitis.

Written By Dr. Syeda Aafia, MBA, BDS,
Reviewed By Dr. Rajeev Sharma, MBA, MBBS,
Last updated on 14 Apr 2026 | 04:21 PM (IST)
₹35569 MRP ₹39992.411% off 
 
 
0
footer-icon
sku_image
Emtux Solution for Infusion is currently sold out
Same composition alternative:
Vortuxi Solution for Infusion
₹30743₹33750
14% cheaper alternative available from Zydus Cadila
Sold out
Emtux Solution for Infusion
Emtux Solution for Infusion
vial of 50 ml Solution for Infusion
₹35569
₹39992.4
tag icon
Same composition
Vortuxi Solution for Infusion
Vortuxi Solution for Infusion
vial of 50 ml Solution for Infusion
by Zydus Cadila
Get by Tomorrow
₹30743
₹594.86 per ml

₹29743

order for
₹1200

Save more with additional offers

offer icon
Pay with Amazon Pay Balance and get cashback up to Rs. 75 with minimum cashback of Rs. 15
Pay with Amazon Pay Balance and get cashback up to Rs. 75 with minimum cashback of Rs. 15
chevron icon
offer icon
Earn cashback up to Rs.75 with Amazon Pay Later
Earn cashback up to Rs.75 with Amazon Pay Later
chevron icon
offer icon
Get upto Rs.500 Cashback on minimum transaction of Rs.999/- with Mobikwik Wallet.
Get upto Rs.500 Cashback on minimum transaction of Rs.999/- with Mobikwik Wallet.
chevron icon
offer icon
Pay with Amazon Pay Balance and get cashback up to Rs. 75 with minimum cashback of Rs. 15
Pay with Amazon Pay Balance and get cashback up to Rs. 75 with minimum cashback of Rs. 15
chevron icon
offer icon
Earn cashback up to Rs.75 with Amazon Pay Later
Earn cashback up to Rs.75 with Amazon Pay Later
chevron icon
offer icon
Get upto Rs.500 Cashback on minimum transaction of Rs.999/- with Mobikwik Wallet.
Get upto Rs.500 Cashback on minimum transaction of Rs.999/- with Mobikwik Wallet.
chevron icon
offer icon
Get upto Rs.150 Cashback on minimum transaction of Rs.599/- with Mobikwik UPI.
Get upto Rs.150 Cashback on minimum transaction of Rs.599/- with Mobikwik UPI.
chevron icon
offer icon
Assured cashback up to ₹300 on minimum payment of ₹300 using Paytm UPI*
Assured cashback up to ₹300 on minimum payment of ₹300 using Paytm UPI*
chevron icon

General Information

The content is shown in English
Emtux Solution for Infusion image
Emtux Solution for Infusion image

Product introduction

Emtux Solution for Infusion is given as an injection under the supervision of doctor. You must take it in a dose as advised by the doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include headache, weakness, edema, infection, and hair loss. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with hepatitis B.

Before taking it, tell your doctor if you have heart disease, liver, or planning surgery or vaccination or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Uses of Emtux Solution for Infusion

Benefits of Emtux Solution for Infusion

Granulomatosis with polyangiitis
Granulomatosis with polyangiitis is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced and it can lead to their damage. Emtux Solution for Infusion helps reduce inflammation, pain and swelling and prevents further damage. This improves your quality of life.
Microscopic polyangiitis
Microscopic polyangiitis is an autoimmune disease which occurs in the small blood vessels and may be caused due to problems with the immune system. Emtux Solution for Infusion reduces immune response and improves inflammation. This helps to heal this condition and improves your discomfort.

Side effects of Emtux Solution for Infusion

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Emtux
  • Headache
  • Weakness
  • Infection
  • Chills
  • Decreased white blood cell count (neutrophils)
  • Fever
  • Infusion site reaction
  • Lymphopenia
  • Abdominal pain
  • Back pain

How to use Emtux Solution for Infusion

Your doctor or nurse will give you this medicine. Kindly do not self-administer.

How Emtux Solution for Infusion works

Emtux Solution for Infusion is a monoclonal antibody. It works by targeting the unwanted activity of immune cells (B cells) in rheumatoid arthritis and certain types of cancers.

All substitutes for Emtux Solution for Infusion

For information purposes only. Consult a doctor before taking any medicine.

Quick tips

  • It is given as a drip (intravenous infusion) by your doctor or nurse.
  • You may be given some painkillers, antihistamine and possibly steroids before the drip to help prevent infusion reaction.
  • Your doctor may get blood tests done to check for hepatitis B before treatment and to monitor your blood cells during treatment with this medicine.
  • Inform your doctor immediately if you notice any signs of infection such as fever, sore throat or rash.
  • Inform your doctor if you are pregnant, planning to conceive or breastfeeding.
  • Inform your doctor  if you have any heart rhythm problems, if you are having surgery or if you plan to get any vaccinations.

Safety advice

Alcohol

Alcohol

CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Emtux Solution for Infusion. Please consult your doctor.
Pregnancy

Pregnancy

CONSULT YOUR DOCTOR
Emtux Solution for Infusion is not recommended during pregnancy as there is positive evidence of fetal risk based on animal studies. However, it may still be prescribed by a doctor in situations where the benefits outweigh the risks.
Breast feeding

Breast feeding

CAUTION
Emtux Solution for Infusion should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from the body.
Driving

Driving

CONSULT YOUR DOCTOR
It is not known whether Emtux Solution for Infusion alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react. Please consult your doctor.
Kidney

Kidney

CAUTION
Emtux Solution for Infusion should be used with caution in patients with severe kidney disease. Dose adjustment may be needed.
Liver

Liver

CAUTION
Emtux Solution for Infusion should be used with caution in patients with liver disease. Dose adjustment may be needed.
Use of Emtux Solution for Infusion is not recommended in patients with the active liver disease or those who had viral hepatitis as it can reactivate the infection.

Interaction with drugs

Taking Emtux with any of the following medicines can modify the effect of either of them and cause some undesirable side effects
Life-threatening

Herpes Zoster / Shingles Vaccine (Recombinant, Adjuvanted) (Injection Route)

Do not use Rituximab with Herpes Zoster / Shingles Vaccine (Recombinant, Adjuvanted). If Rituximab is essential, ensure a gap of at least 12 months after discontinuing Herpes Zoster / Shingles Vaccine (Recombinant, Adjuvanted). Please consult your doctor.
Severe

Cholera Vaccine (Inactivated) (Oral Route)

Do not use Rituximab with Cholera Vaccine (Inactivated). If Rituximab is essential, ensure a gap of at least 12 months after discontinuing Cholera Vaccine (Inactivated). Please consult your doctor.
Severe

Purified Vi Polysaccharide Typhoid Vaccine (Injection Route)

Do not use Rituximab with Purified Vi Polysaccharide Typhoid Vaccine. If Rituximab is essential, ensure a gap of at least 12 months after discontinuing Purified Vi Polysaccharide Typhoid Vaccine. Please consult your doctor.
Moderate

Clozapine (Oral Route)

Your doctor may monitor your blood cell count and adjust the doses as per the observations.
Moderate

Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant (Injection Route)

Please consult with your doctor regarding minimum time interval required between Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant and Rituximab.

Frequently asked questions

Emtux Solution for Infusion is used to treat several immune-related diseases and cancers, including non-Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), granulomatosis with polyangiitis, and microscopic polyangiitis. In rare cases, your doctor may also prescribe this medicine to treat pemphigus vulgaris and moderate to severe rheumatoid arthritis when other treatments have not worked.<br>
Emtux Solution for Infusion helps control overactive immune cells, which play a role in certain cancers and inflammatory diseases. This makes it useful across multiple conditions that involve harmful immune activity.<br>
Emtux Solution for Infusion should not be given to anyone who has had a severe, life-threatening allergic reaction to rituximab or its ingredients in the past. If you have had a serious infusion reaction before, your doctor will consider alternatives.<br>
Serious side effects of Emtux Solution for Infusion include severe infusion reactions, severe skin reactions, heart-related problems, and life-threatening infections. Your doctor and care team will monitor you closely during and after infusions to catch these early.<br>
Yes. Some people may have serious or life-threatening reactions during, or within 24 hours of receiving Emtux Solution for Infusion, including breathing difficulty, swelling, dizziness, or sudden drops in blood pressure. This is why the first dose is given slowly and under close supervision.<br>
Emtux Solution for Infusion can weaken your immune defenses and increase the chance of infections, including serious viral, bacterial, or fungal infections. Rare but severe infections such as progressive multifocal leukoencephalopathy (PML), a brain infection, have been reported. Call your doctor if you develop fever, confusion, weakness, or new neurological symptoms.<br>
Yes. Emtux Solution for Infusion can reactivate the hepatitis B virus in people who previously had the infection. This can be life-threatening. Doctors routinely test for hepatitis B before beginning therapy, and may do regular blood checks during treatment.<br>
Some people experience irregular heartbeat, chest pain, or low blood pressure during Emtux Solution for Infusion infusion. Those with heart problems may need extra monitoring. Report any chest discomfort or unusual heartbeat immediately.<br>
Yes. Before starting Emtux Solution for Infusion, let your doctor know if you have heart disease, lung problems, a current infection, a history of hepatitis B, low immune function, or recent or planned vaccines. These conditions may require additional testing or treatment adjustments.<br>
As Emtux Solution for Infusion lowers certain immune cells for months, some people may have delayed infections or may respond less effectively to vaccines. Doctors often monitor blood tests during and after treatment to ensure immune recovery.<br>

Fact Box

Chemical Class

Peptides

Habit Forming

No

Therapeutic Class

ANTI NEOPLASTICS

Action Class

Anti-CD20 Monoclonal Antibodies

References

  1. Chabner BA, Barnes J, Neal J, et al. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1745-48.
  2. Lake DF, Briggs AD, Akporiaye ET. Immunopharmacology. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 978.
  3. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1225-27.
  4. Rituximab. Garden City, Hertfordshire: Roche Products Limited; 1998 [revised 18 Dec. 2018]. [Accessed 25 Jan. 2019] (online) Available from:
  5. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Rituximab. [Updated 2020 Jan 20]. [Accessed 18 Feb. 2020] (online) Available from:
Related products
Products related to Emtux Solution for Infusion
Related ayurvedic ingredients
100% genuine products
100% genuine products
Safe & secure payments
Safe & secure payments
No contact delivery
No contact delivery
Fully sanitized facilities
Fully sanitized facilities
<h3 class=titleMediumExtraBold>Want to know more</h3>

Want to know more

We provide you with authentic, trustworthy and relevant information
<h3 class=titleMediumExtraBold>Have issue with the content</h3>

Have issue with the content

Disclaimer

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

Marketer details

Name: Emcure Pharmaceuticals Ltd
Address: 255/2, Hinjawadi, Pune - 411057, India / Godown A, Gat No. 408 and 410, Vill: Urse, Tal: Maval, Pune-410 506, Maharashtra, India.

Vendor Details

Country of origin: India
Why we need a prescription?
close sheet